US5972697A
(en)
*
|
1995-11-13 |
1999-10-26 |
The Salk Institute For Biological Studies |
NIMA interacting proteins
|
US7125677B2
(en)
*
|
1995-11-13 |
2006-10-24 |
The Salk Institute For Biological Studies |
NIMA interacting proteins
|
US6277566B1
(en)
*
|
1998-02-13 |
2001-08-21 |
Phillip A. Beachy |
Method for identifying a hedgehog-mediated phosphorylation state dependent transcription factor
|
US20070298423A1
(en)
*
|
2000-03-24 |
2007-12-27 |
Eppendorf Array Technologies Sa (Eat) |
Identification of multiple biological (micro) organisms by specific amplification and detection of their nucleotide sequences on arrays
|
US20080085515A1
(en)
*
|
2000-03-24 |
2008-04-10 |
Eppendorf Array Technologies Sa (Eat) |
Identification of multiple biological (micro) organisms by detection of their nucleotide sequences on arrays
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
US7640484B2
(en)
|
2001-12-28 |
2009-12-29 |
Netapp, Inc. |
Triple parity technique for enabling efficient recovery from triple failures in a storage array
|
EP3115470B1
(en)
*
|
2002-03-13 |
2018-07-18 |
Genomic Health, Inc. |
Gene expression profiling in biopsied tumor tissues
|
US7364846B2
(en)
*
|
2002-10-11 |
2008-04-29 |
Molecular Devices Corporation |
Gene expression profiling from FFPE samples
|
JP4606879B2
(ja)
|
2002-11-15 |
2011-01-05 |
ジェノミック ヘルス, インコーポレイテッド |
Egfr陽性癌の遺伝子発現プロファイリング
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
WO2004070062A2
(en)
*
|
2003-02-04 |
2004-08-19 |
Wyeth |
Compositions and methods for diagnosing and treating cancers
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
CA2527285A1
(en)
*
|
2003-05-28 |
2004-12-23 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
ATE554166T1
(de)
†
|
2003-07-25 |
2012-05-15 |
Life Technologies Corp |
Verfahren und zusammensetzungen zur herstellung von rna aus einer fixierten probe
|
DE10344799A1
(de)
*
|
2003-09-26 |
2005-04-14 |
Ganymed Pharmaceuticals Ag |
Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
|
FR2861744A1
(fr)
*
|
2003-11-05 |
2005-05-06 |
Biomerieux Sa |
Procede pour le pronostic du cancer du sein
|
WO2005064019A2
(en)
*
|
2003-12-23 |
2005-07-14 |
Genomic Health, Inc. |
Universal amplification of fragmented rna
|
US20100190150A1
(en)
*
|
2004-01-07 |
2010-07-29 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
|
US20050221398A1
(en)
*
|
2004-01-16 |
2005-10-06 |
Ipsogen, Sas, A Corporation Of France |
Protein expression profiling and breast cancer prognosis
|
US20070270488A1
(en)
*
|
2004-03-12 |
2007-11-22 |
The Queen's University Of Belfast |
Treatment and Assays
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
ES2550614T3
(es)
|
2004-04-09 |
2015-11-11 |
Genomic Health, Inc. |
Marcadores de expresión génica para predecir la respuesta a la quimioterapia
|
KR20070057761A
(ko)
*
|
2004-06-04 |
2007-06-07 |
아비아라디엑스, 인코포레이티드 |
종양의 확인방법
|
US20120258442A1
(en)
*
|
2011-04-09 |
2012-10-11 |
bio Theranostics, Inc. |
Determining tumor origin
|
US20060068418A1
(en)
*
|
2004-07-09 |
2006-03-30 |
Godfrey Tony E |
Identification of markers in lung and breast cancer
|
DE102004042822A1
(de)
*
|
2004-08-31 |
2006-03-16 |
Technische Universität Dresden |
Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
CA2586201A1
(en)
*
|
2004-11-03 |
2006-05-11 |
Almac Diagnostics Limited |
Transcriptome microarray technology and methods of using the same
|
CA3061785A1
(en)
*
|
2004-11-05 |
2006-05-18 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
WO2006052731A2
(en)
|
2004-11-05 |
2006-05-18 |
Genomic Health, Inc. |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
US8535914B2
(en)
*
|
2005-01-21 |
2013-09-17 |
Canon Kabushiki Kaisha |
Probe, probe set and information acquisition method using the same
|
CA2601157A1
(en)
|
2005-03-16 |
2006-09-28 |
Osi Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
|
US8383357B2
(en)
*
|
2005-03-16 |
2013-02-26 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
|
US20080193938A1
(en)
*
|
2005-04-01 |
2008-08-14 |
Yu Kun |
Materials And Methods Relating To Breast Cancer Classification
|
US20060246492A1
(en)
|
2005-04-05 |
2006-11-02 |
The General Hospital Corporation |
Method for predicting responsiveness to drugs
|
US20060275844A1
(en)
*
|
2005-04-19 |
2006-12-07 |
Linke Steven P |
Diagnostic markers of breast cancer treatment and progression and methods of use thereof
|
CN101297045A
(zh)
|
2005-06-03 |
2008-10-29 |
阿威亚拉德克斯股份有限公司 |
肿瘤和组织的鉴定
|
US20070099209A1
(en)
*
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
US8921102B2
(en)
*
|
2005-07-29 |
2014-12-30 |
Gpb Scientific, Llc |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
US7700299B2
(en)
*
|
2005-08-12 |
2010-04-20 |
Hoffmann-La Roche Inc. |
Method for predicting the response to a treatment
|
US8129114B2
(en)
*
|
2005-08-24 |
2012-03-06 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
|
WO2007030611A2
(en)
*
|
2005-09-09 |
2007-03-15 |
The Board Of Regents Of The University Of Texas System |
A calculated index of genomic expression of estrogen receptor (er) and er related genes
|
WO2007035842A2
(en)
*
|
2005-09-21 |
2007-03-29 |
Ccc Diagnostics, Llc |
Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac)
|
US7723112B2
(en)
|
2005-10-31 |
2010-05-25 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
US20070128636A1
(en)
*
|
2005-12-05 |
2007-06-07 |
Baker Joffre B |
Predictors Of Patient Response To Treatment With EGFR Inhibitors
|
EP2487257B1
(en)
*
|
2006-01-05 |
2015-07-01 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
|
JP2009536313A
(ja)
|
2006-01-11 |
2009-10-08 |
レインダンス テクノロジーズ, インコーポレイテッド |
ナノリアクターの形成および制御において使用するマイクロ流体デバイスおよび方法
|
RU2436098C2
(ru)
|
2006-02-09 |
2011-12-10 |
Юниверсити Оф Саут Флорида |
Детектирование рака яичника по повышенным уровням bcl-2 в моче
|
US7888019B2
(en)
|
2006-03-31 |
2011-02-15 |
Genomic Health, Inc. |
Genes involved estrogen metabolism
|
CN101240331A
(zh)
*
|
2006-04-07 |
2008-08-13 |
甄二真 |
基于mEPHX基因多态性的皮肤美容保健方法
|
US20070254305A1
(en)
*
|
2006-04-28 |
2007-11-01 |
Nsabp Foundation, Inc. |
Methods of whole genome or microarray expression profiling using nucleic acids prepared from formalin fixed paraffin embedded tissue
|
EP2530168B1
(en)
|
2006-05-11 |
2015-09-16 |
Raindance Technologies, Inc. |
Microfluidic Devices
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
WO2007137187A2
(en)
|
2006-05-18 |
2007-11-29 |
Molecular Profiling Institute, Inc. |
System and method for determining individualized medical intervention for a disease state
|
US8768629B2
(en)
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
US8372584B2
(en)
|
2006-06-14 |
2013-02-12 |
The General Hospital Corporation |
Rare cell analysis using sample splitting and DNA tags
|
US8137912B2
(en)
|
2006-06-14 |
2012-03-20 |
The General Hospital Corporation |
Methods for the diagnosis of fetal abnormalities
|
WO2007147074A2
(en)
|
2006-06-14 |
2007-12-21 |
Living Microsystems, Inc. |
Use of highly parallel snp genotyping for fetal diagnosis
|
US20080050739A1
(en)
|
2006-06-14 |
2008-02-28 |
Roland Stoughton |
Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
|
AU2007273055B2
(en)
*
|
2006-07-14 |
2014-05-01 |
The Regents Of The University Of California |
Cancer biomarkers and methods of use thereof
|
WO2008021123A1
(en)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Fluorocarbon emulsion stabilizing surfactants
|
US20080118576A1
(en)
*
|
2006-08-28 |
2008-05-22 |
Dan Theodorescu |
Prediction of an agent's or agents' activity across different cells and tissue types
|
US20080096208A1
(en)
*
|
2006-09-06 |
2008-04-24 |
Connors Richard W |
Biomarkers for assessing response to c-met treatment
|
US7615349B2
(en)
*
|
2006-09-07 |
2009-11-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Melanoma gene signature
|
DK2081950T3
(da)
*
|
2006-09-21 |
2013-06-03 |
Nuclea Biomarkers Llc |
Med irinotecanbehandling forbundne ekspressionsprofiler
|
JP5041580B2
(ja)
*
|
2006-10-17 |
2012-10-03 |
一般財団法人化学及血清療法研究所 |
仲介ポリヌクレオチド
|
US20080125358A1
(en)
*
|
2006-10-26 |
2008-05-29 |
University Of Massachusetts Medical School |
Methods for Chk2 inhibitor patient selection
|
KR100862972B1
(ko)
|
2006-10-30 |
2008-10-13 |
한국과학기술연구원 |
휘발성 유기 화합물 검색용 바이오마커 및 이를 이용한유해성을 나타내는 휘발성 유기 화합물 검색 방법
|
WO2008063521A2
(en)
*
|
2006-11-13 |
2008-05-29 |
The General Hospital Corporation |
Gene-based clinical scoring system
|
KR100886670B1
(ko)
|
2007-01-11 |
2009-03-04 |
김현기 |
유두갑상선암의 새로운 진단마커 및 진단방법
|
US8148147B2
(en)
|
2007-01-24 |
2012-04-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
US8772046B2
(en)
|
2007-02-06 |
2014-07-08 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
JP2010524003A
(ja)
*
|
2007-04-13 |
2010-07-15 |
ブリストル−マイヤーズ スクイブ カンパニー |
血管内皮増殖因子受容体−2モジュレーターに対する感受性を決定するためのバイオマーカーおよび方法
|
EP2134860A1
(en)
|
2007-04-13 |
2009-12-23 |
OSI Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to kinase inhibitors
|
WO2008130623A1
(en)
|
2007-04-19 |
2008-10-30 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
WO2008150937A2
(en)
*
|
2007-05-29 |
2008-12-11 |
Aivaradx, Inc. |
Real-time pcr
|
AU2008260075A1
(en)
|
2007-05-31 |
2008-12-11 |
California Pacific Medical Center |
Method to predict or diagnose a gastrointestinal disorder or disease
|
US9551033B2
(en)
|
2007-06-08 |
2017-01-24 |
Genentech, Inc. |
Gene expression markers of tumor resistance to HER2 inhibitor treatment
|
CA2690334C
(en)
|
2007-06-08 |
2017-02-14 |
Genentech, Inc. |
Gene expression markers of tumor resistance to her2 inhibitor treatment
|
US8053186B2
(en)
|
2007-06-15 |
2011-11-08 |
The Ohio State University Research Foundation |
Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing
|
US8883440B2
(en)
|
2007-07-26 |
2014-11-11 |
Nancy M. Lee |
Method to predict or diagnose a gastrointestinal disorder or disease
|
CN101835902B
(zh)
|
2007-08-03 |
2014-03-26 |
俄亥俄州立大学研究基金会 |
编码ncrna的超保守区域
|
CA2694703A1
(en)
*
|
2007-08-16 |
2009-02-26 |
Aventis Inc. |
Gene expression markers of recurrence risk in cancer patients after chemotherapy
|
EP2028600B1
(en)
|
2007-08-24 |
2016-10-26 |
Sysmex Corporation |
Diagnosis support system for cancer, diagnosis support for information providing method for cancer, and computer program product
|
US9388457B2
(en)
|
2007-09-14 |
2016-07-12 |
Affymetrix, Inc. |
Locus specific amplification using array probes
|
CA2699385A1
(en)
*
|
2007-09-14 |
2009-03-19 |
Ventana Medical Systems, Inc. |
Prostate cancer biomarkers
|
US8716190B2
(en)
|
2007-09-14 |
2014-05-06 |
Affymetrix, Inc. |
Amplification and analysis of selected targets on solid supports
|
US8048621B2
(en)
|
2007-10-03 |
2011-11-01 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
US7939272B2
(en)
|
2007-10-03 |
2011-05-10 |
Osi Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
WO2009048901A1
(en)
*
|
2007-10-09 |
2009-04-16 |
University Of Washington |
Quantitative/semi-quantitative measurement of epor on cancer cells
|
ES2538362T3
(es)
|
2007-10-16 |
2015-06-19 |
Ventana Medical Systems, Inc. |
Clasificación, estadificación y pronóstico del cáncer mediante el uso de osteopontina-C
|
WO2009055559A1
(en)
*
|
2007-10-23 |
2009-04-30 |
University Of South Florida |
Method of predicting chemotherapeutic responsiveness of cancer
|
AU2008316577B2
(en)
|
2007-10-26 |
2014-04-10 |
The Ohio State University Research Foundation |
Methods for identifying fragile histidine triad (FHIT) interaction and uses thereof
|
EP2065473A1
(en)
*
|
2007-11-28 |
2009-06-03 |
Siemens Healthcare Diagnostics GmbH |
A method to assess prognosis and to predict therapeutic success in gynecologic cancer
|
WO2009068423A2
(en)
|
2007-11-30 |
2009-06-04 |
Siemens Healthcare Diagnostics Gmbh |
Method for predicting therapy responsiveness in basal like tumors
|
US8476420B2
(en)
*
|
2007-12-05 |
2013-07-02 |
The Wistar Institute Of Anatomy And Biology |
Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells
|
US10416162B2
(en)
|
2007-12-20 |
2019-09-17 |
Monogram Biosciences, Inc. |
Her2 diagnostic methods
|
EP2641978A1
(en)
|
2008-05-12 |
2013-09-25 |
Genomic Health, Inc. |
Tests to predict responsiveness of cancer patients to chemotherapy treatment options
|
WO2009140409A1
(en)
*
|
2008-05-14 |
2009-11-19 |
Genomic Health Inc. |
Predictors of patient response to treatment with egf receptor inhibitors
|
US20110318732A1
(en)
*
|
2008-05-28 |
2011-12-29 |
Singer Robert H |
Prediction of chemotherapeutic response via single-cell profiling of transcription site activation
|
AU2009257410B2
(en)
|
2008-06-11 |
2014-03-06 |
Fudan University |
Use of miR-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
|
BRPI0812682A2
(pt)
|
2008-06-16 |
2010-06-22 |
Genentech Inc |
tratamento de cáncer de mama metastático
|
WO2010009365A1
(en)
|
2008-07-18 |
2010-01-21 |
Raindance Technologies, Inc. |
Droplet libraries
|
US8583380B2
(en)
|
2008-09-05 |
2013-11-12 |
Aueon, Inc. |
Methods for stratifying and annotating cancer drug treatment options
|
US10359425B2
(en)
*
|
2008-09-09 |
2019-07-23 |
Somalogic, Inc. |
Lung cancer biomarkers and uses thereof
|
CA3069081C
(en)
|
2008-09-20 |
2023-05-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Noninvasive diagnosis of fetal aneuploidy by sequencing
|
US9332973B2
(en)
|
2008-10-01 |
2016-05-10 |
Covidien Lp |
Needle biopsy device with exchangeable needle and integrated needle protection
|
US11298113B2
(en)
|
2008-10-01 |
2022-04-12 |
Covidien Lp |
Device for needle biopsy with integrated needle protection
|
US9186128B2
(en)
|
2008-10-01 |
2015-11-17 |
Covidien Lp |
Needle biopsy device
|
US9782565B2
(en)
|
2008-10-01 |
2017-10-10 |
Covidien Lp |
Endoscopic ultrasound-guided biliary access system
|
US8968210B2
(en)
|
2008-10-01 |
2015-03-03 |
Covidien LLP |
Device for needle biopsy with integrated needle protection
|
US20100221752A2
(en)
*
|
2008-10-06 |
2010-09-02 |
Somalogic, Inc. |
Ovarian Cancer Biomarkers and Uses Thereof
|
WO2010045318A2
(en)
*
|
2008-10-14 |
2010-04-22 |
Caris Mpi, Inc. |
Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
|
EP2722400A3
(en)
*
|
2008-10-29 |
2014-07-09 |
William Beaumont Hospital |
Methods of using biomarkers
|
GB2463401B
(en)
|
2008-11-12 |
2014-01-29 |
Caris Life Sciences Luxembourg Holdings S A R L |
Characterizing prostate disorders by analysis of microvesicles
|
EP2438442B1
(en)
|
2008-12-01 |
2017-08-09 |
Laboratory Corporation of America Holdings |
Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95
|
US20120041274A1
(en)
|
2010-01-07 |
2012-02-16 |
Myriad Genetics, Incorporated |
Cancer biomarkers
|
WO2010083470A1
(en)
|
2009-01-15 |
2010-07-22 |
Laboratory Corporation Of America Holdings |
Methods of determining patient response by measurement of her-3
|
WO2010083463A1
(en)
*
|
2009-01-15 |
2010-07-22 |
Laboratory Corporation Of America Holdings |
Methods of determining patient response by measurement of her-2 expression
|
US20110171124A1
(en)
*
|
2009-02-26 |
2011-07-14 |
Osi Pharmaceuticals, Inc. |
In situ methods for monitoring the EMT status of tumor cells in vivo
|
EP3415235A1
(en)
|
2009-03-23 |
2018-12-19 |
Raindance Technologies Inc. |
Manipulation of microfluidic droplets
|
EP2425021A4
(en)
*
|
2009-05-01 |
2013-03-06 |
Nuvera Biosciences Inc |
INDEX OF GENOMEXPRESSION OF ESTROGEN RECEPTOR (ER) AND ER-ASSOCIATED GENES
|
WO2010135411A2
(en)
*
|
2009-05-19 |
2010-11-25 |
The Regents Of The University Of Colorado |
Aurora-a copy number and sensitivity to inhibitors
|
EP2278026A1
(en)
*
|
2009-07-23 |
2011-01-26 |
Université de la Méditerranée |
A method for predicting clinical outcome of patients with breast carcinoma
|
EP2475988B1
(en)
|
2009-09-09 |
2018-11-14 |
The General Hospital Corporation |
Use of microvesicles in analyzing nucleic acid profiles
|
WO2011038063A1
(en)
|
2009-09-28 |
2011-03-31 |
The Trustees Of The University Of Pennsylvania |
Method of diagnosing and treating interstitial cystitis
|
WO2011042564A1
(en)
|
2009-10-09 |
2011-04-14 |
Universite De Strasbourg |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
US7736861B1
(en)
*
|
2009-10-19 |
2010-06-15 |
Aveo Pharmaceuticals, Inc. |
Tivozanib response prediction
|
US20110123990A1
(en)
*
|
2009-11-23 |
2011-05-26 |
Baker Joffre B |
Methods To Predict Clinical Outcome Of Cancer
|
AU2010321555B2
(en)
|
2009-11-23 |
2015-10-15 |
The Ohio State University |
Materials and methods useful for affecting tumor cell growth, migration and invasion
|
EP2507396A4
(en)
*
|
2009-12-01 |
2013-06-19 |
Precision Therapeutics Inc |
MULTI-MEDICATION RESPONSE MARKERS FOR BREAST CANCER CELLS
|
US10837883B2
(en)
|
2009-12-23 |
2020-11-17 |
Bio-Rad Laboratories, Inc. |
Microfluidic systems and methods for reducing the exchange of molecules between droplets
|
JP6286124B2
(ja)
|
2010-01-11 |
2018-02-28 |
ジェノミック ヘルス, インコーポレイテッド |
遺伝子発現を用いて腎癌の臨床的結果の見込みを判定する方法
|
US20130011393A1
(en)
*
|
2010-01-12 |
2013-01-10 |
Johnathan Mark Lancaster |
Bad pathway gene signature
|
JP5934657B2
(ja)
|
2010-02-12 |
2016-06-15 |
レインダンス テクノロジーズ, インコーポレイテッド |
デジタル検体分析
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US20130143753A1
(en)
*
|
2010-03-01 |
2013-06-06 |
Adelbio |
Methods for predicting outcome of breast cancer, and/or risk of relapse, response or survival of a patient suffering therefrom
|
CA2791905A1
(en)
|
2010-03-01 |
2011-09-09 |
Caris Life Sciences Luxembourg Holdings, S.A.R.L. |
Biomarkers for theranostics
|
AU2011223655A1
(en)
*
|
2010-03-03 |
2012-06-28 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
WO2011109637A1
(en)
*
|
2010-03-03 |
2011-09-09 |
Koo Foundation Sun Yat-Sen Cancer Center |
Methods for classifying and treating breast cancers
|
US8597202B2
(en)
|
2010-03-30 |
2013-12-03 |
Siteselect Medical Technologies, Inc. |
Tissue excision device with a modified cutting edge
|
KR101346955B1
(ko)
*
|
2010-03-30 |
2014-01-02 |
서울대학교산학협력단 |
뇌종양의 재발 가능성 및 생존 예후 예측용 조성물 및 이를 포함하는 키트
|
JP5553661B2
(ja)
*
|
2010-03-30 |
2014-07-16 |
シスメックス株式会社 |
癌の再発リスク判定方法
|
AU2011237669B2
(en)
|
2010-04-06 |
2016-09-08 |
Caris Life Sciences Switzerland Holdings Gmbh |
Circulating biomarkers for disease
|
EP3508854A1
(en)
*
|
2010-04-27 |
2019-07-10 |
The Regents of The University of California |
Cancer biomarkers and methods of use thereof
|
WO2011150245A2
(en)
*
|
2010-05-26 |
2011-12-01 |
Expression Pathology, Inc. |
Urokinase-type plasminogen activator protein/plasminogen activator inhibitor type-1 protein-selected reaction monitoring assay
|
WO2012006447A2
(en)
|
2010-07-07 |
2012-01-12 |
Myriad Genetics, Inc. |
Gene signatures for cancer prognosis
|
US20130116150A1
(en)
|
2010-07-09 |
2013-05-09 |
Somalogic, Inc. |
Lung Cancer Biomarkers and Uses Thereof
|
DE102010033575B4
(de)
|
2010-08-02 |
2016-01-14 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
ASPP2-Splicevariante
|
SG2014007454A
(en)
|
2010-08-13 |
2014-07-30 |
Somalogic Inc |
Pancreatic cancer biomarkers and uses thereof
|
US9605319B2
(en)
|
2010-08-30 |
2017-03-28 |
Myriad Genetics, Inc. |
Gene signatures for cancer diagnosis and prognosis
|
EP3447155A1
(en)
|
2010-09-30 |
2019-02-27 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
CA2816603A1
(en)
|
2010-11-12 |
2012-05-18 |
The Ohio State University Research Foundation |
Materials and methods related to microrna-21, mismatch repair, and colorectal cancer
|
AU2011329066B2
(en)
|
2010-11-15 |
2017-03-09 |
The Ohio State University Research Foundation |
Controlled release mucoadhesive systems
|
WO2012090073A2
(en)
*
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
WO2012097368A2
(en)
*
|
2011-01-14 |
2012-07-19 |
Response Genetics, Inc. |
Her3 and her4 primers and probes for detecting her3 and her4 mrna expression
|
WO2012109233A2
(en)
*
|
2011-02-07 |
2012-08-16 |
Board Of Regents, The University Of Texas System |
Methods for predicting recurrence risk in breast cancer patients
|
WO2012109600A2
(en)
|
2011-02-11 |
2012-08-16 |
Raindance Technologies, Inc. |
Methods for forming mixed droplets
|
EP2675819B1
(en)
|
2011-02-18 |
2020-04-08 |
Bio-Rad Laboratories, Inc. |
Compositions and methods for molecular labeling
|
AU2012225506B2
(en)
|
2011-03-07 |
2016-11-17 |
The Ohio State University |
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer
|
WO2012149014A1
(en)
|
2011-04-25 |
2012-11-01 |
OSI Pharmaceuticals, LLC |
Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
EP2714970B1
(en)
|
2011-06-02 |
2017-04-19 |
Raindance Technologies, Inc. |
Enzyme quantification
|
WO2013006502A1
(en)
*
|
2011-07-01 |
2013-01-10 |
Pinpoint Genomics, Inc. |
Method for extracting rna from fixed embedded tissue
|
WO2013010074A1
(en)
|
2011-07-13 |
2013-01-17 |
Primeradx, Inc. |
Multimodal methods for simultaneous detection and quantification of multiple nucleic acids in a sample
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
GB201114919D0
(en)
*
|
2011-08-30 |
2011-10-12 |
Glaxosmithkline Biolog Sa |
Method
|
CN102533740B
(zh)
*
|
2011-09-07 |
2013-07-24 |
杭州艾迪康医学检验中心有限公司 |
人白血病融合基因bcr-abl的rt-pcr引物及其使用方法
|
EP2766500A4
(en)
|
2011-10-14 |
2015-10-14 |
Univ Ohio State |
METHODS AND MATERIALS RELATED TO OVARIAN CANCER
|
JP6147755B2
(ja)
*
|
2011-11-08 |
2017-06-14 |
ジェノミック ヘルス, インコーポレイテッド |
乳癌の予後を予測する方法
|
CN103145845A
(zh)
*
|
2011-12-06 |
2013-06-12 |
吉林圣元科技有限责任公司 |
Tat与人野生型P53融合蛋白在毕赤酵母中的表达
|
US9481885B2
(en)
|
2011-12-13 |
2016-11-01 |
Ohio State Innovation Foundation |
Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis
|
CA2866052A1
(en)
|
2012-01-20 |
2013-07-25 |
The Ohio State University |
Breast cancer biomarker signatures for invasiveness and prognosis
|
EP3495817A1
(en)
|
2012-02-10 |
2019-06-12 |
Raindance Technologies, Inc. |
Molecular diagnostic screening assay
|
EP3524693A1
(en)
|
2012-04-30 |
2019-08-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
NZ703411A
(en)
|
2012-06-27 |
2017-09-29 |
Berg Llc |
Use of markers in the diagnosis and treatment of prostate cancer
|
WO2014078700A1
(en)
|
2012-11-16 |
2014-05-22 |
Myriad Genetics, Inc. |
Gene signatures for cancer prognosis
|
US20140186468A1
(en)
*
|
2012-12-07 |
2014-07-03 |
Susana Gonzalo |
Diagnosing subsets of triple-negative breast cancer
|
WO2014113641A1
(en)
|
2013-01-18 |
2014-07-24 |
Kline Ellis |
Selective glycosidase regimen for immune programming and treatment of cancer
|
EP2954331B1
(en)
|
2013-02-11 |
2018-03-28 |
Incuron LLC |
Use of facilitates chromatin transcription complex (fact) in cancer
|
EP2986762B1
(en)
|
2013-04-19 |
2019-11-06 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US9637798B2
(en)
|
2013-05-21 |
2017-05-02 |
Dignity Health |
Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer
|
JP2016521979A
(ja)
|
2013-05-30 |
2016-07-28 |
ジェノミック ヘルス, インコーポレイテッド |
腎臓がんを有する患者に対する再発スコアを計算するための遺伝子発現プロファイルアルゴリズム
|
WO2015048098A1
(en)
*
|
2013-09-24 |
2015-04-02 |
Washington University |
Diagnostic methods for infectious disease using endogenous gene expression
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
WO2015103367A1
(en)
|
2013-12-31 |
2015-07-09 |
Raindance Technologies, Inc. |
System and method for detection of rna species
|
WO2015175692A1
(en)
|
2014-05-13 |
2015-11-19 |
Myriad Genetics, Inc. |
Gene signatures for cancer prognosis
|
CN106795557A
(zh)
|
2014-06-02 |
2017-05-31 |
瓦利保健系统公司 |
用于肺癌诊断的方法和系统
|
US9994912B2
(en)
|
2014-07-03 |
2018-06-12 |
Abbott Molecular Inc. |
Materials and methods for assessing progression of prostate cancer
|
EP3517954A1
(en)
*
|
2014-10-17 |
2019-07-31 |
Assistance Publique - Hôpitaux de Paris |
Methods for the monitoring and prognosis of a bladder cancer
|
ES2857953T3
(es)
|
2014-10-24 |
2021-09-29 |
Koninklijke Philips Nv |
Pronóstico médico y predicción de la respuesta al tratamiento usando las actividades de múltiples rutas de señalización celular
|
DK3210142T3
(da)
|
2014-10-24 |
2020-11-16 |
Koninklijke Philips Nv |
Vurdering af tgf-cellulær signaleringsvejaktivitet under anvendelse af matematisk modellering af målgenekspression
|
EP3210144B1
(en)
|
2014-10-24 |
2020-10-21 |
Koninklijke Philips N.V. |
Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities
|
EP3227687A4
(en)
|
2014-12-05 |
2018-10-24 |
Prelude, Inc. |
Dcis recurrence and invasive breast cancer
|
AU2015360694B2
(en)
|
2014-12-08 |
2021-10-14 |
Berg Llc |
Use of markers including filamin a in the diagnosis and treatment of prostate cancer
|
EP3331558B1
(en)
|
2015-08-06 |
2024-05-15 |
The Wistar Institute Of Anatomy And Biology |
Combination therapies targeting mitochondrial biogenesis for cancer therapy
|
AU2016309659A1
(en)
|
2015-08-14 |
2018-04-12 |
Koninklijke Philips N.V. |
Assessment of NFkB cellular signaling pathway activity using mathematical modelling of target gene expression
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
RU2018145532A
(ru)
|
2016-06-21 |
2020-07-23 |
Зе Уистар Инститьют Оф Анатоми Энд Байолоджи |
Композиции и способы диагностирования раковых заболеваний легких с помощью профилей экспрессии генов
|
US10487365B2
(en)
|
2016-09-20 |
2019-11-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for detecting expression of lnc-FANCI-2 in cervical cells
|
WO2018093797A1
(en)
|
2016-11-15 |
2018-05-24 |
The Schepens Eye Research Institute, Inc. |
Compositions and methods for the treatment of aberrant angiogenesis
|
KR101950717B1
(ko)
*
|
2016-11-23 |
2019-02-21 |
주식회사 젠큐릭스 |
유방암 환자의 화학치료 유용성 예측 방법
|
US10636512B2
(en)
|
2017-07-14 |
2020-04-28 |
Cofactor Genomics, Inc. |
Immuno-oncology applications using next generation sequencing
|
US10998178B2
(en)
|
2017-08-28 |
2021-05-04 |
Purdue Research Foundation |
Systems and methods for sample analysis using swabs
|
EP3461915A1
(en)
|
2017-10-02 |
2019-04-03 |
Koninklijke Philips N.V. |
Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression
|
WO2019099560A1
(en)
|
2017-11-14 |
2019-05-23 |
The Schepens Eye Research Institute, Inc. |
Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
|
EP3502279A1
(en)
|
2017-12-20 |
2019-06-26 |
Koninklijke Philips N.V. |
Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression
|
CN110045120A
(zh)
*
|
2018-01-15 |
2019-07-23 |
长庚医疗财团法人基隆长庚纪念医院 |
检测生物样品中wisp1的浓度在制备用于乳癌筛检及侦测复发的检测试剂盒及其应用
|
WO2020056162A1
(en)
*
|
2018-09-12 |
2020-03-19 |
Oregon Health & Science University |
Detecting and/or subtyping circulating hybrid cells that correlate with stage and survival
|
AU2019339508A1
(en)
|
2018-09-14 |
2021-04-15 |
Prelude Corporation |
Method of selection for treatment of subjects at risk of invasive breast cancer
|
WO2020178399A1
(en)
|
2019-03-05 |
2020-09-10 |
Norwegian University Of Science And Technology (Ntnu) |
Breast cancer signature genes
|
WO2021154146A1
(en)
*
|
2020-01-30 |
2021-08-05 |
Arocell Ab |
Predicting patient survival
|
KR20240004290A
(ko)
*
|
2021-04-21 |
2024-01-11 |
아폴로믹스 인코포레이티드 |
C-met 억제제를 이용한 암의 진단 및 치료
|
EP4253567A1
(en)
*
|
2022-03-31 |
2023-10-04 |
OncoAssure Limited |
A method of predicting risk of an aggressive or recurrent cancer
|